Redwoods Acquisition Corp.
RWOD
NASDAQ Global Market2.34
USD
-3.45
- -
Redwoods Acquisition Corp.
RWOD
(NASDAQ Global Market)
Recent
price
2.34
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Redwoods Acquisition Corp. is a special purpose acquisition company (SPAC) primarily focused on effecting mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or other similar business combinations with one or more businesses. Incorporated in 2021 and headquartered in New York, New York, the company initially targeted opportunities in the carbon-neutral and energy storage industries. Redwoods Acquisition Corp. completed its initial public offering in April 2022, raising $100 million to support its acquisition strategy. In a significant development in June 2024, Redwoods Acquisition Corp. consummated a business combination with ANEW Medical, Inc., a biopharmaceutical technology company specializing in diagnostics and therapies for neurological and age-related disorders, particularly treatments targeting central nervous system and neurodegenerative diseases. Following this merger, the combined entity continues trading on the Nasdaq exchange under the ticker symbols WENA and WENAW for its common shares and warrants, respectively. This strategic transaction marked a major pivot for Redwoods Acquisition Corp., transitioning its business focus to the biopharmaceutical sector, leveraging ANEW Medical's pipeline of gene therapy platform technologies to drive growth and shareholder value. The company maintains operations targeting therapeutic innovation in the CNS and aging-related disease markets, reflecting a comprehensive shift from its original energy sector emphasis to an advanced biotech profile. The merger included a forward purchase agreement with strategic investors Meteora Capital Partners and others, further solidifying its capital structure and growth backing.
ANEW MEDICAL, INC. COMMENCES TRADING ON NASDAQ UNDER TICKER SYMBOL, "WENA"
ANEW MEDICAL, INC. and REDWOOD ACQUISITION CORP.
RWOD Stock: 7 Things to Know About the Anew Medical Merger
Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today?
ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS